CABRI, WALTER
 Distribuzione geografica
Continente #
AS - Asia 8.355
NA - Nord America 7.375
EU - Europa 5.955
Continente sconosciuto - Info sul continente non disponibili 669
SA - Sud America 464
AF - Africa 385
OC - Oceania 12
Totale 23.215
Nazione #
US - Stati Uniti d'America 7.190
IT - Italia 2.383
SG - Singapore 2.244
CN - Cina 2.058
VN - Vietnam 1.709
DE - Germania 799
IN - India 780
GB - Regno Unito 716
HK - Hong Kong 512
SE - Svezia 444
FR - Francia 347
BR - Brasile 319
RU - Federazione Russa 265
BD - Bangladesh 197
IE - Irlanda 195
JP - Giappone 193
KR - Corea 183
NL - Olanda 147
UA - Ucraina 121
CA - Canada 104
CI - Costa d'Avorio 103
FI - Finlandia 96
TG - Togo 90
ZA - Sudafrica 87
CH - Svizzera 86
AR - Argentina 68
PH - Filippine 63
TW - Taiwan 60
ID - Indonesia 59
HR - Croazia 56
PL - Polonia 50
SC - Seychelles 48
TH - Thailandia 48
MX - Messico 46
TR - Turchia 44
ES - Italia 42
JO - Giordania 36
AT - Austria 32
PK - Pakistan 29
IQ - Iraq 28
BE - Belgio 23
BG - Bulgaria 21
CL - Cile 19
SA - Arabia Saudita 19
MY - Malesia 17
GR - Grecia 16
PT - Portogallo 15
DZ - Algeria 14
CO - Colombia 13
DK - Danimarca 13
EC - Ecuador 13
IR - Iran 13
RO - Romania 13
AU - Australia 11
CZ - Repubblica Ceca 11
EG - Egitto 10
LV - Lettonia 10
PY - Paraguay 10
HU - Ungheria 9
NP - Nepal 9
JM - Giamaica 8
AE - Emirati Arabi Uniti 7
BY - Bielorussia 7
EE - Estonia 7
UZ - Uzbekistan 7
VE - Venezuela 7
LB - Libano 6
MA - Marocco 6
PE - Perù 6
SK - Slovacchia (Repubblica Slovacca) 6
AL - Albania 5
CR - Costa Rica 5
IL - Israele 5
LT - Lituania 5
MD - Moldavia 5
BO - Bolivia 4
GT - Guatemala 4
MU - Mauritius 4
PR - Porto Rico 4
PS - Palestinian Territory 4
RS - Serbia 4
TN - Tunisia 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CY - Cipro 3
ET - Etiopia 3
HN - Honduras 3
OM - Oman 3
BA - Bosnia-Erzegovina 2
GE - Georgia 2
KE - Kenya 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
MO - Macao, regione amministrativa speciale della Cina 2
SI - Slovenia 2
SN - Senegal 2
TT - Trinidad e Tobago 2
UG - Uganda 2
AM - Armenia 1
AO - Angola 1
Totale 22.517
Città #
Singapore 1.567
San Jose 671
Ashburn 659
Bologna 630
Chandler 613
Santa Clara 559
Southend 543
Hong Kong 452
Ho Chi Minh City 380
Hefei 356
Hanoi 350
Princeton 303
Fairfield 294
Beijing 261
Council Bluffs 236
Boardman 201
Dublin 191
Wilmington 180
Dallas 166
Lauterbourg 160
Berlin 154
Milan 153
Dong Ket 148
Seoul 145
Tokyo 143
Woodbridge 126
Seattle 120
Houston 116
Des Moines 113
Los Angeles 110
Abidjan 103
Cambridge 100
New York 99
Lomé 90
Rome 88
Buffalo 86
Westminster 81
Medford 78
Redondo Beach 72
Helsinki 71
Hyderabad 66
Pune 66
Shanghai 65
Da Nang 64
Ann Arbor 63
Guangzhou 60
The Dalles 60
Bengaluru 58
Chicago 57
Columbus 57
Haiphong 56
São Paulo 55
Forlì 54
Ferrara 50
Duncan 48
Frankfurt am Main 45
Redwood City 45
Johannesburg 44
Jinan 42
Turin 42
Jakarta 40
Cesena 39
Naples 39
Florence 38
Amman 35
Tianjin 34
Nanjing 33
Olalla 33
Phoenix 32
Redmond 31
San Diego 31
Warsaw 31
Paris 30
Orem 29
Chengdu 28
Nuremberg 27
Amsterdam 26
Shenzhen 26
Chennai 25
Hangzhou 25
London 25
Montreal 25
Mumbai 25
Bern 23
Padova 23
Toronto 23
Atlanta 22
Delhi 22
Genoa 22
Mexico City 22
Munich 22
San Francisco 22
Biên Hòa 21
Sofia 21
Zhengzhou 21
Moscow 20
Bühl 19
Lappeenranta 19
Lavis 19
Palermo 19
Totale 13.132
Nome #
An Improved Process for the Preparation of Semaglutide Side Chain.” 473
Green Solvent Mixtures for Solid-Phase Peptide Synthesis: A Dimethylformamide-Free Highly Efficient Synthesis of Pharmaceutical-Grade Peptides 378
Replacing piperidine in Solid Phase Peptide Synthesis: effective Fmoc removal by alternative bases 365
Fast Solution-Phase and Liquid-Phase Peptide Syntheses (SolPSS and LPPS) Mediated by Biomimetic Cyclic Propylphosphonic Anhydride (T3P®) 312
Ampicillin sodium: Isolation, identification and synthesis of the last unknown impurity after 60 years of clinical use 302
Speeding up sustainable solution-phase peptide synthesis using T3P® as a green coupling reagent: methods and challenges 301
Copper-Free Heck−Cassar−Sonogashira and Suzuki−Miyaura Reactions of Aryl Chlorides: A Sustainable Approach 270
Method for the FMOC group cleavage 265
From green innovations in oligopeptide to oligonucleotide sustainable synthesis: differences and synergies in TIDES chemistry 258
Application of Af4-Multidetection to Liraglutide in Its Formulation: Preserving and Representing Native Aggregation 252
Pharmaceutical green chemistry in peptide synthesis A snapshot on the role of solvents in SPPS 250
A Sustainable Chemo-Enzymatic Approach to the Synthesis of Liraglutide 249
Fast Heck−Cassar−Sonogashira (HCS) Reactions in Green Solvents 241
Palladium Catalyst Recycling for Heck-Cassar-Sonogashira Cross-Coupling Reactions in Green Solvent/Base Blend 239
Process for the preparation of alectinib 233
New Mechanistic Insights into the Copper-Free Heck-Cassar-Sonogashira Cross-Coupling Reaction 227
Fast MacMillan's Imidazolidinone-Catalyzed Enantioselective Synthesis of Polyfunctionalized 4-Isoxazoline Scaffolds 225
Dimethyl carbonate as a green alternative to acetonitrile in reversed-phase liquid chromatography. Part II: purification of a therapeutic peptide 223
Steps towards sustainable solid phase peptide synthesis: use and recovery of N-octyl pyrrolidone 214
Green Chemistry Impact and Evolution in the Pharma Industry 209
A translation of the twelve principles of green chemistry to guide the development of cross-coupling reactions 207
Dimethyl carbonate as a green alternative to acetonitrile in reversed-phase liquid chromatography. Part I: Separation of small molecules 199
Carbodiimide-Mediated Beckmann Rearrangement of Oxyma-B as a Side Reaction in Peptide Synthesis 197
Process for the Synthesis of Propofol 192
Process for the Synthesis, of Etelcacetide 191
Therapeutic Peptides Targeting PPI in Clinical Development: Overview, Mechanism of Action and Perspectives 184
Rediscovery of an Old Named Reaction: From Micellar Catalysis to Unusual Schotten−Baumann Conditions 183
Novel insights into the chemistry of an old medicine: A general degradative pathway for penicillins from a piperacillin/tazobactam stability study 181
Biotechnological lycopene production by mated fermentation of Blakeslea trispora 174
Benefits of a Mixed-Mode Stationary Phase to Address the Challenging Purification of an Industrially Relevant Peptide: A Proof-of-Concept Study 174
Solid phase peptide synthesis using side-chain unprotected arginine and histidine with Oxyma Pure/TBEC in green solvents 173
Sustainability in peptide chemistry: current synthesis and purification technologies and future challenges. 173
Azetidinones as Zinc-Binding Groups to Design Selective HDAC8 Inhibitors 172
Boosting basic-peptide separation through dynamic electrostatic-repulsion reversed-phase (d-ERRP) liquid chromatography 171
Investigation of the GnRH antagonist degarelix isomerization in biological matrices 160
Process for the Synthesis of Nangibotide.” 159
Blakeslea trispora genes for carotene biosynthesis 158
2-Azetidinones: synthesis of new bis(indolyl)butyl-beta-lactams 155
PROCESS FOR THE PREPARATION OF PROPOFOL 154
Ganoderma lucidum Ethanol Extracts Enhance Re-Epithelialization and Prevent Keratinocytes from Free-Radical Injury 154
An Improved Process for The Preparation of Ribociclib and its Salts 153
Process Intensification for the Purification of Peptidomimetics: The Case of Icatibant through Multicolumn Countercurrent Solvent Gradient Purification (MCSGP) 150
E-ring-modified 7-oxyiminomethyl camptothecins: Synthesis and preliminary in vitro and in vivo biological evaluation 147
Cefdinir: A comparative study of anhydrous vs. monohydrate form Microstructure and tabletting behaviour 146
Aminocarnitine Ureidic Derivatives as Inhibitors of Carnitine Palmitoyltransferase I 145
Understanding Glucagon Aggregation: In Silico Insights and Experimental Validation 141
A New Approach to Supramolecular Structure Determination in Pharmaceutical Preparation of Self-Assembling Peptides: A Case Study of Lanreotide Autogel 141
A Process for the Preparing Treosulfan 140
Thermodynamic and kinetic investigation of monoketo-aldehyde- peroxyhemiacetal (MKA), a stereolabile degradation product of dihydroartemisinin 139
Catalysis: A key technology for a green approach to pharmaceutical production 139
100- “Biotransformation of Colchicinoids into Their Corresponding 3-O-Glucosyl Derivatives by Selected Strains of Bacillus megaterium 139
High-throughput enantioseparation of Nα-fluorenylmethoxycarbonyl proteinogenic amino acids through fast chiral chromatography on zwitterionic-teicoplanin stationary phases 137
Overcoming chemical challenges in the solid-phase synthesis of high-purity GnRH antagonist Degarelix. Part 2 136
A Process for Preparing Alectinib or a Pharmaceutically Acceptable Salt Thereof 135
Mastering palladium-catalyzed cross-coupling reactions: the critical role of in situ pre-catalyst reduction design 134
CARBAMATE DERIVATIVES IN PARTICULAR FOR THE TREATMENT OF NEUROLOGICAL DISORDERS 133
Development of a practical high-yield industrial synthesis of pergolide mesylate 133
Process for the manufacturing of glucagon.” 132
From batch to continuous chromatographic purification of a therapeutic peptide through Multicolumn Countercurrent Solvent Gradient Purification (MCSGP) 132
4,5,6,7-Tetrahydro-isoxazolo-[4,5-c]-pyridines as a new class of cytotoxic Hsp90 inhibitors. 128
a A Process For Purification of Carfilzomib Intermediate 127
Process for the preparation of Degarelix 127
Aryl isoxazole compounds with antitumoral Activities 126
Assessing the performance of new chromatographic technologies for the separation of peptide epimeric impurities: the case of Icatibant 125
On-column epimerization of dihydroartemisinin: An effective analytical approach to overcome the shortcomings of the International Pharmacopoeia monograph 124
Expanding the Use of Dynamic Electrostatic Repulsion Reversed-Phase Chromatography: An Effective Elution Mode for Peptides Control and Analysis 124
Downstream Processing of Therapeutic Peptides by Means of Preparative Liquid Chromatography 123
ARYL TRIAZOLE COMPOUNDS WITH ANTITUMOURAL ACTIVITY 122
SUBTILISIN VARIANTS AND THEIR USE 121
Process for the Purification of Tacrolimus 121
Stereolability of MKA, a rearrangement product of dihydroartemisinin endowed with antimalarian activity 120
Camptothecins in tumor homing via an RGD sequence mimetic 119
Polymorphisms and patent, market, and legal battles: Cefdinir case study 117
Stereolability of Dihydroartemisinin, an Antimalarial Life-Saving Drug: a Comprehensive Kinetic Investigation - Part II 116
Process for the Manufacture of Derivatized Amino Acids 116
New approach to Tacrolimus Purification 116
An Improved Process For The Preparation of Sugammadex Which Involves The Use of a Salt Of 3-mercapto Propionic Acid, Preferably The Di Sodium Salt Of 3-mercapto Propionic Acid 115
An Improved Process For The Preparation of Sugammadex And Its Intermediates 113
Aminooxime derivatives of 2 and/or 4 substitued androstanes and androstenes as medicaments for cardiovascular disorders 113
Catalysis: The pharmaceutical perspective 113
Copper(II) Lysinate and Pseudoproline Assistance in the Convergent Synthesis of the GLP-1 Receptor Agonists Liraglutide and Semaglutide 112
AMORPHOUS FORM OF A THIOCOLCHICINE DERIVATIVE 112
Modeling the nonlinear behavior of a bioactive peptide in reversed-phase gradient elution chromatography 112
Reducing effect of the Chinese medicinal herb, Salvia miltiorrhiza, on alcohol self-administration in Sardinian alcohol-preferring rats” 112
Evolution of an acylase active on cephalosporin C 111
METHOD FOR ICATIBANT PREPARATION 110
Improving Solid-State Properties of the Side-Chain Peptide Building Blocks for the Synthesis of GLP-1 Analogs through Their Complexation with Metal Cations 109
An Improved Process for the Preparation of Ixazomib citrate 109
Samital a new botanical drug for the treatment of mucosities induced by oncological therapies 109
Crystalline form of Cefdinir ammonium salt as an intermediate for the preparation of pure Cefdinir 107
Epoxidation of 17-oxo-15,16-methylene steroids with sulfoxonium ylides 107
Synthesis and biological activity of fluorinated combretastatin analogues 106
Combination of HPLC "Inverted chirality columns approach" and MS/MS detection for extreme enantiomeric excess determination even in absence of reference samples. Application to camptothecin derivatives 106
Natural lycopene from Blakeslea trispora: all-trans lycopene thermochemical and structural properties 106
Recovery of Bioactive Compounds from Artichokes Brines by nanofiltration 106
Vorinostat-Like Molecules as Structural, Stereochemical, and Pharmacological Tools 105
Industrial Synthesis Design With Low Environmental Impact In The Pharma Industry 104
omega-Alkoxy analogues of SAHA (vorinostat) as inhibitors of HDAC: A study of chain-length and stereochemical dependence 104
Identification of a novel arylpiperazine scaffold for fatty acid amide hydrolase inhibition with improved drug disposition properties 103
Stereoselective process and crystalline forms of a camptothecin 102
Totale 16.327
Categoria #
all - tutte 70.850
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.850


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.285 0 95 256 79 267 246 76 212 124 115 302 513
2022/20233.078 455 403 147 320 232 265 222 195 438 134 155 112
2023/20241.322 74 155 91 74 107 201 105 182 51 142 46 94
2024/20254.027 131 594 309 335 769 247 403 172 117 159 207 584
2025/20269.459 488 870 893 638 846 537 1.069 438 2.088 662 516 414
2026/2027532 293 239 0 0 0 0 0 0 0 0 0 0
Totale 23.215